Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
1.070
+0.060 (5.94%)
At close: Jan 23, 2026
ETR:MAK Market Cap
ETR:MAK has a market cap or net worth of €22.44 million as of January 23, 2026. Its market cap has decreased by -24.11% in one year.
Market Cap
22.44M
Enterprise Value
21.80M
Revenue
116.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.07
Market Cap Chart
Since February 17, 1998, ETR:MAK's market cap has decreased from 110.87M to 22.44M, a decrease of -79.76%. That is a compound annual growth rate of -5.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 22.44M | 4.90% |
| Dec 30, 2025 | 21.39M | -25.00% |
| Dec 30, 2024 | 28.52M | -52.45% |
| Dec 29, 2023 | 59.97M | 71.26% |
| Dec 29, 2022 | 35.02M | -65.64% |
| Dec 30, 2021 | 101.91M | 10.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.52B |
| Siemens Healthineers AG | 48.31B |
| Bayer Aktiengesellschaft | 43.77B |
| Fresenius SE & Co. KGaA | 27.24B |
| Pentixapharm Holding AG | 49.57M |
| MeVis Medical Solutions AG | 47.32M |
| Cantourage Group SE | 40.15M |
| aap Implantate AG | 21.14M |